EUVIMEDEUVIMED entdecken
Open Access

Gut Microbiota and Metabolomics Insights into the Gualou-Xiebai Herb Pair for Dyslipidemia and Atherosclerosis

Ni Wang, Yanan Xu, Jiahui Li, Chunsheng Li, Zijian Liu, Zhenglong Li, Yarong Liu, Yexiang Zhang, An Zhou, Hongfei Wu

Journal of Microbiology and Biotechnology · 2025

DOI: 10.4014/jmb.2510.10023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Ni Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, P.R. China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Dyslipidemias, Atherosclerosis, Drugs, Chinese Herbal. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Provincial University Natural Science Research Project of Anhui, Natural Science Foundation of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a chronic lipid driven arterial disease, dyslipidemia is one of the most critical risk factors for atherosclerosis (AS). The gut microbiota plays an important role in regulating host lipid metabolism disorders. Studies have shown that the herb "Gualou-Xiebai" (GLXB) can effectively regulate the blood lipid levels of ApoE -/- mice and inhibit blood lipid accumulation. However, it is not yet clear whether GLXB herb pair can alleviate lipid abnormalities in AS diseases by inhibiting cholesterol absorption. Meanwhile, the regulatory effect of GLXB herb pair on gut microbiota metabolites needs further research. Therefore, ApoE-/- mice were used to establish a dyslipidemia model with a HFD approach, and the contents of the cecum of the mice were collected for a gut microbiota study and to analyze how the GLXB herbal pair ameliorates dyslipidemia through the gut microbiota in ApoE-/- mice. The results showed that the GLXB herb pair can significantly increase metabolites propionic acid and butyric acid levels in the gut microbiota. In addition, cellular experiments demonstrated that butyric acid significantly reduced cholesterol levels in Caco-2 cells, and western blot results showed that the GLXB herb pair inhibited the expression of NPC1L1, ACAT2, MTP, and ApoB48 proteins by increasing the level of butyric acid. In conclusion, the GLXB herb pair exerts a therapeutic effect on dyslipidemia in ApoE -/- mice by decreasing intestinal cholesterol absorption in ApoE-/- mice by increasing the level of butyric acid, a metabolite of the gut microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDyslipidemiasAtherosclerosisDrugs, Chinese HerbalAnimalsMiceHumansCaco-2 CellsMaleLipid MetabolismApolipoproteins ECholesterolMetabolomicsMice, Inbred C57BLDisease Models, AnimalMice, KnockoutMice, Knockout, ApoEDiet, High-Fat

Stichwörter der Autor:innen

Gualou-Xiebai herb paircholesteroldyslipidemiagut microbiotashort-chain fatty acids

Substanzen

Drugs, Chinese HerbalApolipoproteins ECholesterol

Autor:innen und Institutionen

  • School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, P.R. China.
  • Department of Cardiovascular Surgery, Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P.R. China.
  • The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, P.R. China.
  • Anhui Province Key Laboratory of Research & Development of Chinese Medicine, Hefei 230012, P.R. China.

Förderung

  • National Natural Science Foundation of China
  • Provincial University Natural Science Research Project of Anhui
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Wang, N., Xu, Y., Li, J., Li, C., Liu, Z., Li, Z., Liu, Y., Zhang, Y., Zhou, A., & Wu, H. (2025). Gut Microbiota and Metabolomics Insights into the Gualou-Xiebai Herb Pair for Dyslipidemia and Atherosclerosis. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2510.10023

Vancouver

Wang N, Xu Y, Li J, Li C, Liu Z, Li Z, et al. Gut Microbiota and Metabolomics Insights into the Gualou-Xiebai Herb Pair for Dyslipidemia and Atherosclerosis. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2510.10023

BibTeX
@article{Wang2025,
  author = {Wang, Ni and Xu, Yanan and Li, Jiahui and Li, Chunsheng and Liu, Zijian and Li, Zhenglong and Liu, Yarong and Zhang, Yexiang and Zhou, An and Wu, Hongfei},
  title = {Gut Microbiota and Metabolomics Insights into the Gualou-Xiebai Herb Pair for Dyslipidemia and Atherosclerosis},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2025},
  doi = {10.4014/jmb.2510.10023}
}
Kostenlos starten →